These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 8346077

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Chronicles in drug discovery.
    Moral MA, Khurdayan VK, Bozzo J.
    Drug News Perspect; 2006 Oct; 19(8):485-9. PubMed ID: 17160149
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Anti-carcinogenic soyabean Bowman-Birk inhibitors survive faecal fermentation in their active form and do not affect the microbiota composition in vitro.
    Marín-Manzano MC, Ruiz R, Jiménez E, Rubio LA, Clemente A.
    Br J Nutr; 2009 Apr; 101(7):967-71. PubMed ID: 19353764
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Enzymatic and Algebraic Methodology to Determine the Contents of Kunitz and Bowman-Birk Inhibitors and Their Contributions to Total Trypsin or Chymotrypsin Inhibition in Soybeans.
    Liu K.
    J Agric Food Chem; 2024 May 22; 72(20):11782-11793. PubMed ID: 38717295
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Treatment with soybean-derived Bowman Birk inhibitor increases serum prostate-specific antigen concentration while suppressing growth of human prostate cancer xenografts in nude mice.
    Wan XS, Ware JH, Zhang L, Newberne PM, Evans SM, Clark LC, Kennedy AR.
    Prostate; 1999 Dec 01; 41(4):243-52. PubMed ID: 10544297
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Potential intracellular target proteins of the anticarcinogenic Bowman Birk protease inhibitor identified by affinity chromatography.
    Billings PC, St Clair W, Owen AJ, Kennedy AR.
    Cancer Res; 1988 Apr 01; 48(7):1798-802. PubMed ID: 3280120
    [Abstract] [Full Text] [Related]

  • 54. Contents and bioactivities of lunasin, bowman-birk inhibitor, and isoflavones in soybean seed.
    Park JH, Jeong HJ, de Lumen BO.
    J Agric Food Chem; 2005 Oct 05; 53(20):7686-90. PubMed ID: 16190617
    [Abstract] [Full Text] [Related]

  • 55. The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases.
    Clemente A, Moreno FJ, Marín-Manzano Mdel C, Jiménez E, Domoney C.
    Mol Nutr Food Res; 2010 Mar 05; 54(3):396-405. PubMed ID: 19885848
    [Abstract] [Full Text] [Related]

  • 56. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH, Wan XS, Rubin H, Schechter NM, Kennedy AR.
    Arch Biochem Biophys; 1997 Aug 01; 344(1):133-8. PubMed ID: 9244390
    [Abstract] [Full Text] [Related]

  • 57. Identification and characterization of a Bowman-Birk inhibitor active towards trypsin but not chymotrypsin in Lupinus albus seeds.
    Scarafoni A, Consonni A, Galbusera V, Negri A, Tedeschi G, Rasmussen P, Magni C, Duranti M.
    Phytochemistry; 2008 Jun 01; 69(9):1820-5. PubMed ID: 18474386
    [Abstract] [Full Text] [Related]

  • 58. Development of Bowman-Birk inhibitor for chemoprevention of oral head and neck cancer.
    Meyskens FL.
    Ann N Y Acad Sci; 2001 Dec 01; 952():116-23. PubMed ID: 11795430
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.